Also called: HBV
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Hepatitis B
Hepatitis is inflammation of the liver. Inflammation is swelling that happens when tissues of the body are injured or infected. It can damage your liver. This swelling and damage can affect how well your liver functions.
Hepatitis B is a type of viral hepatitis. It can cause an acute (short-term) or chronic (long-term) infection. People with an acute infection usually get better on their own without treatment. Some people with chronic hepatitis B will need treatment.
Thanks to a vaccine, hepatitis B is not very common in the United States. It is more common in certain parts of the world, such as sub-Saharan Africa and parts of Asia.
Hepatitis B is caused by the hepatitis B virus. The virus spreads through contact with blood, semen, or other body fluids from a person who has the virus.
Anyone can get hepatitis B, but the risk is higher in:
- Infants born to mothers who have hepatitis B
- People who inject drugs or share needles, syringes, and other types of drug equipment
- Sex partners of people with hepatitis B, especially if they are not using latex or polyurethane condoms during sex
- Men who have sex with men
- People who live with someone who has hepatitis B, especially if they use the same razor, toothbrush, or nail clippers
- Health care and public-safety workers who are exposed to blood on the job
- Hemodialysis patients
- People who have lived in or traveled often to parts of the world where hepatitis B is common
- People who have diabetes, hepatitis C, or HIV
Often, people with hepatitis B don't have symptoms. Adults and children over 5 are more likely to have symptoms than younger children.
Some people with acute hepatitis B have symptoms 2 to 5 months after infection. These symptoms can include:
- Dark yellow urine
- Diarrhea
- Fatigue
- Fever
- Gray- or clay-colored stools
- Joint pain
- Loss of appetite
- Nausea and/or vomiting
- Abdominal pain
- Yellowish eyes and skin, called jaundice
If you have chronic hepatitis B, you may not have symptoms until complications develop. This could be decades after you were infected. For this reason, hepatitis B screening is important, even if you have no symptoms. Screening means that you are tested for a disease even though you don't have symptoms. If you are at high risk, your health care provider may suggest screening.
In rare cases, acute hepatitis B can cause liver failure.
Chronic hepatitis B can develop into a serious disease that causes long-term health problems such as cirrhosis (scarring of the liver), liver cancer, and liver failure.
If you have ever had hepatitis B, the virus may become active again, or reactivated, later in life. This could start to damage the liver and cause symptoms.
To diagnose hepatitis B, your health care provider may use many tools to make a diagnosis:
- A medical history, which includes asking about your symptoms
- A physical exam
- Blood tests, including tests for viral hepatitis
If you have acute hepatitis B, you probably don't need treatment. Some people with chronic hepatitis B don't need treatment. But if you have a chronic infection and blood tests show that hepatitis B could be damaging your liver, you may need to take antiviral medicines.
The best way to prevent hepatitis B is to get the hepatitis B vaccine.
You can also reduce your chance of hepatitis B infection by:
- Not sharing drug needles or other drug materials
- Wearing gloves if you have to touch another person's blood or open sores
- Making sure your tattoo artist or body piercer uses sterile tools
- Not sharing personal items, such as toothbrushes, razors, or nail clippers
- Using a latex condom during sex. If your or your partner is allergic to latex, you can use polyurethane condoms.
If you think you have been in contact with the hepatitis B virus, see your health care provider right away. Your provider may give you a dose of the hepatitis B vaccine to prevent infection. In some cases, your provider may also give you a medicine called hepatitis B immune globulin (HBIG). You need to get the vaccine and the HBIG (if needed) as soon as possible after coming into contact with the virus. It is best if you can get them within 24 hours.
National Institute of Diabetes and Digestive and Kidney Diseases
It sits within Digestive System and Infections.
The lead U.S. institute for this subject is the National Institute of Diabetes and Digestive and Kidney Diseases.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Hepatitis B
2,046 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.Eunice Dube
- A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis BAusper Biopharma Co., Ltd.
- Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)Ausper Biopharma Co., Ltd.
- Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 InjectionAusper Biopharma Co., Ltd.
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.Ausper Biopharma Co., Ltd.
Research already completed
- Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis BAsan Medical Center
- Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome TypesFoshan Hospital of Traditional Chinese Medicine
- Analysis of Renal Impairment Characteristics and High-Risk Factors in Chronic Hepatitis B Patients on Long-Term Oral Nucleos(t)Ide AnaloguesFoshan Hospital of Traditional Chinese Medicine
- Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) InfectionBrii Biosciences Limited
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases
- Hepatitis BAmerican Academy of Family Physicians
- Hepatitis B BasicsCenters for Disease Control and Prevention
- Hepatitis B Prevention and ControlCenters for Disease Control and Prevention
- Hepatitis B: Patient's GuideDepartment of Veterans Affairs
Diagnosis and Tests
- Hepatitis PanelNational Library of Medicine
- Liver Function TestsNational Library of Medicine
Treatments and Therapies
- Approved Drugs for AdultsHepatitis B Foundation
- Treatment Options for Hepatitis BHepatitis B Foundation
Prevention and Risk Factors
- Hepatitis B Vaccine SafetyCenters for Disease Control and Prevention
- Prevention Tips for Hepatitis BHepatitis B Foundation
Living With
- Adults Living with Hepatitis BHepatitis B Foundation
Related Issues
- Hepatitis B and CHIV.gov
- Hepatitis DNational Institute of Diabetes and Digestive and Kidney Diseases
- HIV and Hepatitis BNational Institutes of Health, Office of AIDS Research
- Infectious Diseases in Persons Who Inject DrugsCenters for Disease Control and Prevention
- Know HBV: What Every Asian and Pacific Islander Should Know About Hepatitis B and Liver CancerAsian Liver Center at Stanford University
Statistics and Research
- FastStats: Viral HepatitisNational Center for Health Statistics
- Viral Hepatitis Surveillance Report: United States, 2020Centers for Disease Control and Prevention
Clinical Trials
- ClinicalTrials.gov: Hepatitis BNational Institutes of Health
Patient Handouts
- Hepatitis B Vaccine: What You Need to KnowCenters for Disease Control and Prevention
Medical subject headings
Clinicians and researchers index this subject under Hepatitis B. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Hepatitis B, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.